Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Janus Kinase Inhibitor”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Testing effectiveness (Phase 2)Study completedNCT05016297
What this trial is testing

Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 87
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Large-scale testing (Phase 3)Study completedNCT04006457
What this trial is testing

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 1,057
Large-scale testing (Phase 3)Ended earlyNCT03920254
What this trial is testing

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Who this might be right for
Ulcerative Colitis (UC)
Theravance Biopharma 46
Testing effectiveness (Phase 2)Looking for participantsNCT05980806
What this trial is testing

Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Who this might be right for
MyelofibrosisModerate ThrombocytopeniaMild Thrombocytopenia
Karyopharm Therapeutics Inc 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07530224
What this trial is testing

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

Who this might be right for
Immune Checkpoint Inhibitor-Induced Dermatitis
Shixiu Wu 35
Testing effectiveness (Phase 2)Study completedNCT03144687
What this trial is testing

Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 23
Large-scale testing (Phase 3)Study completedNCT06238817
What this trial is testing

Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 241
Post-approval studies (Phase 4)Looking for participantsNCT07160231
What this trial is testing

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek 200
Early research (Phase 1)Study completedNCT03766399
What this trial is testing

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Who this might be right for
Asthma
AstraZeneca 131
Post-approval studies (Phase 4)Study completedNCT03886038
What this trial is testing

Subunit Vaccine Against Herpes Zoster in RA Patients Treated With JAK-inhibitors (VACCIMIL-ZOSTER)

Who this might be right for
Rheumatoid ArthritisHealthy Controls
Region Skane 142
Not applicableStudy completedNCT06177405
What this trial is testing

Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors

Who this might be right for
Rheumatoid Arthritis
Institute of Biomedical Chemistry, Russia 50
Large-scale testing (Phase 3)Study completedNCT04173494
What this trial is testing

Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis
Sierra Oncology LLC - a GSK company 195
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Testing effectiveness (Phase 2)Study completedNCT06020014
What this trial is testing

Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

Who this might be right for
Asthma
AstraZeneca 339
Not applicableEnrolling By InvitationNCT06688838
What this trial is testing

Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome

Who this might be right for
Blau Syndrome
Tongji Hospital 24
Testing effectiveness (Phase 2)UnknownNCT04640532
What this trial is testing

KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

Who this might be right for
MyelofibrosisPost-PV MFPost-ET Myelofibrosis+1 more
Kartos Therapeutics, Inc. 116
Testing effectiveness (Phase 2)Study completedNCT05696795
What this trial is testing

Janus Kinase Inhibition in Sarcoidosis

Who this might be right for
Sarcoidosis
Yale University 10
Post-approval studies (Phase 4)Study completedNCT05313620
What this trial is testing

Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

Who this might be right for
Ulcerative ColitisThromboembolism
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 32
Next Page